US Stock MarketDetailed Quotes
PEPG PepGen
- 17.250
- -0.230-1.32%
Close Jun 14 16:00 ET
- 17.250
- 0.0000.00%
Post 16:05 ET
559.20MMarket Cap-5324P/E (TTM)
17.500High16.940Low49.20KVolume17.380Open17.480Pre Close848.58KTurnover0.31%Turnover RatioLossP/E (Static)32.42MShares18.38052wk High3.12P/B273.95MFloat Cap3.72052wk Low--Dividend TTM15.88MShs Float20.000Historical High--Div YieldTTM3.20%Amplitude3.720Historical Low17.246Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
PepGen Stock Forum
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US)$
$Vaxcyte(PCVX.US)$
$Legend Biotech(LEGN.US)$
$Janux Therapeutics(JANX.US)$
$Aerovate(AVTE.US)$
$Rhythm Pharmaceuticals(RYTM.US)$
$Evolent Health(EVH.US)$
$NewAmsterdam Pharma(NAMS.US)$
$RxSight(RXST.US)$
$TYRA BIOSCIENCES, INC.(TYRA.US)$
$Edgewise Therapeutics(EWTX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Biogen(BIIB.US)$
$PepGen(PEPG.US)$
...
PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that the first patient has been dosed in its CONNECT1-EDO51 Phase 2, open-label multiple ascending dose (MAD) clinical trial evaluating PGN-EDO51 for the ...
Benzinga· 5 mins ago
$Acumen Pharmaceuticals(ABOS.US)$ $Altus Power(AMPS.US)$ $Abasca Resources Inc(AMV.CA)$ $Coupang(CPNG.US)$ $Disney(DIS.US)$ $Klx Energy Services(KLXE.US)$ $Mind Medicine(MNMD.US)$ $PepGen(PEPG.US)$ $SOBR Safe(SOBR.US)$ $Top Ships(TOPS.US)$ $Windtree Therapeutics(WINT.US)$
ABOS PEPG TOPS AAPL DIS XPEV MNMD TSM QTRX
$Acumen Pharmaceuticals(ABOS.US)$ $PepGen(PEPG.US)$ $Top Ships(TOPS.US)$ $Apple(AAPL.US)$ $Disney(DIS.US)$ $XPeng(XPEV.US)$ $Mind Medicine(MNMD.US)$ $Taiwan Semiconductor(TSM.US)$ $Quanterix(QTRX.US)$
No comment yet